These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4092197)

  • 1. Mitoxantrone in adenocarcinoma of the endometrium: a Southwest Oncology Group Study.
    Hilgers RD; Von Hoff DD; Stephens RL; Boutselis JG; Rivkin SE
    Cancer Treat Rep; 1985 Nov; 69(11):1329-30. PubMed ID: 4092197
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II trial of mitoxantrone in previously untreated patients with colorectal adenocarcinoma: A Southwest Oncology Group Study.
    Cowan JD; Von Hoff DD; McDonald B; Talley RW; McCracken JD; Chen T
    Cancer Treat Rep; 1982 Sep; 66(9):1779-80. PubMed ID: 7116355
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study.
    Taylor SA; Von Hoff DD; Baker LH; Balcerzak SP
    Cancer Treat Rep; 1984 Jun; 68(6):919-20. PubMed ID: 6733708
    [No Abstract]   [Full Text] [Related]  

  • 4. Mitoxantrone and advanced squamous cell carcinoma of the cervix: a Southwest Oncology Group Study.
    Hilgers RD; Von Hoff DD; Stephens RL; Boutselis JG
    Cancer Treat Rep; 1986 Apr; 70(4):527-8. PubMed ID: 3698047
    [No Abstract]   [Full Text] [Related]  

  • 5. Mitoxantrone for treatment of patients with refractory small cell carcinoma of the lung: a Southwest Oncology Group Study.
    Von Hoff DD; Chen T; Clark GM; Callahan SK; Livingston R
    Cancer Treat Rep; 1983 Apr; 67(4):403-4. PubMed ID: 6303588
    [No Abstract]   [Full Text] [Related]  

  • 6. Mitoxantrone for carcinoma of the endometrium: a phase II trial of the Gynecologic Oncology Group.
    Muss HB; Bundy BN; DiSaia PJ; Ehrlich CE
    Cancer Treat Rep; 1987 Feb; 71(2):217-8. PubMed ID: 3802120
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II trial of mitoxantrone in advanced colorectal cancer.
    Bonnem EM; Mitchell EP; Woolley PV; Smith FP; Neefe J; Smith L; Schein PS
    Cancer Treat Rep; 1982 Nov; 66(11):1995-6. PubMed ID: 7139642
    [No Abstract]   [Full Text] [Related]  

  • 8. Mitoxantrone therapy of advanced adenocarcinoma of the endometrium. A phase II trial.
    Runge HM; Meerpohl HG; Pfleiderer A
    Onkologie; 1989 Apr; 12(2):102-3. PubMed ID: 2660047
    [No Abstract]   [Full Text] [Related]  

  • 9. Mitoxantrone: modest activity in a phase II trial in advanced prostate cancer.
    Osborne CK; Drelichman A; Von Hoff DD; Crawford ED
    Cancer Treat Rep; 1983 Dec; 67(12):1133-5. PubMed ID: 6652630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Medroxyprogesterone and endometrial adenocarcinoma].
    Serment H; Spitalier JM; Ayme Y; Degiovanni E; Bardin JP
    Bull Fed Soc Gynecol Obstet Lang Fr; 1970; 22(1):93-7. PubMed ID: 5453572
    [No Abstract]   [Full Text] [Related]  

  • 11. [Preliminary note on histologic changes induced by a new synthetic gestagen (19-nor-17-alpha-hydroxyprogesterone capronate) on adenocarcinoma of the endometrium].
    Vecchione A; Ruozi Berretta L
    Riv Anat Patol Oncol; 1968; 33():431-60. PubMed ID: 5760166
    [No Abstract]   [Full Text] [Related]  

  • 12. Medrogestone therapy in advanced endometrial adenocarcinoma.
    Waterman EA; Benson RC
    Obstet Gynecol; 1967 Nov; 30(5):626-34. PubMed ID: 4167865
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study.
    Levin M; Pandya KJ; Khandekar JD; Horton J; Glick JH; Bennett JM; Muggia FM; Falkson G
    Cancer Treat Rep; 1984 Dec; 68(12):1511-2. PubMed ID: 6509455
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II clinical study of tamoxifen in advanced endometrial adenocarcinoma: a Gynecologic Oncology Group study.
    Slavik M; Petty WM; Blessing JA; Creasman WT; Homesley HD
    Cancer Treat Rep; 1984 May; 68(5):809-11. PubMed ID: 6722836
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of adenocarcinoma of the endometrium with synthetic progestogens].
    Lanza A; Fedele M; Renzetti ME; Ferraris G
    Minerva Ginecol; 1981 Oct; 33(10):917-36. PubMed ID: 7031519
    [No Abstract]   [Full Text] [Related]  

  • 16. [Synthetic progestational hormones in high doses in adenocarcinoma of the endometrium. (Study of carbohydrate metabolism)].
    Pasquinucci C
    Minerva Ginecol; 1970 Oct; 22(19):950-6. PubMed ID: 5516459
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II evaluation of dianhydrogalactitol in the treatment of advanced endometrial adenocarcinoma: a Gynecologic Oncology Group Study.
    Stehman FB; Blessing JA; Delgado G; Louka M
    Cancer Treat Rep; 1983; 67(7-8):737-8. PubMed ID: 6871892
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of gestagen on uterine adenocarcinoma of the endometrium in the human, with special reference to electron microscope study].
    Hayakawa K; Okudaira Y; Nasu K; Iijima H; Taki I
    Nihon Sanka Fujinka Gakkai Zasshi; 1968 Nov; 20(11):1528-9. PubMed ID: 5752842
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of medroxyprogesterone (MAP) therapy on the DNA content in adenocarcinoma of the human endometrium].
    Vecchietti G; Gerzeli G; Zanoio L; Novelli GG; Barni S
    Minerva Ginecol; 1979; 31(7-8):597-603. PubMed ID: 481819
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serumimmunologic findings in the course of citostal therapy in patients with endometrial adenoma].
    Montemagno U; Cardone A; Di Stefano M
    Arch Ostet Ginecol; 1969; 74(1):50-7. PubMed ID: 4102087
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.